Name: UMIN ID:
Unique ID issued by UMIN | UMIN000038644 |
---|---|
Receipt number | R000042017 |
Scientific Title | A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer. |
Date of disclosure of the study information | 2019/11/20 |
Last modified on | 2022/01/06 10:12:12 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/11/20 14:52:38 | ||
2 | Update | 2020/09/16 09:34:10 | Recruitment status Date of IRB |
|
3 | Update | 2021/01/14 19:02:57 | TEL TEL Tel1 |
|
4 | Update | 2021/01/14 19:03:40 | Last follow-up date |
|
5 | Update | 2022/01/06 10:12:12 | Tel1 Email1 |